Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance

Xianming Huang, Claudia Gottstein, Rolf A. Brekken, Philip E. Thorpe

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Vascular endothelial growth factor (VEGF) is an endothelial cell specific mitogen that induces angiogenesis in several pathological conditions. To block angiogenesis, soluble VEGF receptor can be used. In this study, we describe a method for high yield expression of soluble VEGF receptor 2 (sFlk-1) in a baculovirus expression system (30 mg purified sFlk-1 per L of insect cell supernatant). We also determined the binding constants for both human and mouse VEGF to the recombinant receptor by surface plasmon resonance. In this cell-free assay, under the given experimental conditions, the on-rate k(a) was 0.5-2.2 x 106 M-1 s-1 and the off-rate k(d) was 2-4 x 10-4 s-1 (K(D) = 2-6 x 10-10 M). To our knowledge this is the first study to report on- and off-rates for the VEGF:sFlk-1 interaction. Heparin was not required for the binding of VEGF to sFlk-1 in this assay. The obtained values will serve as baseline parameters for the design of improved versions of recombinant soluble VEGF receptor.

Original languageEnglish (US)
Pages (from-to)643-648
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume252
Issue number3
DOIs
StatePublished - Nov 27 1998

Fingerprint

Vascular Endothelial Growth Factor Receptor-2
Surface Plasmon Resonance
Surface plasmon resonance
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor
Assays
Baculoviridae
Mitogens
Insects
Heparin
Endothelial cells
Endothelial Cells

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance. / Huang, Xianming; Gottstein, Claudia; Brekken, Rolf A.; Thorpe, Philip E.

In: Biochemical and Biophysical Research Communications, Vol. 252, No. 3, 27.11.1998, p. 643-648.

Research output: Contribution to journalArticle

@article{a29750564e7f460abd5ca3ef14d9acd7,
title = "Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance",
abstract = "Vascular endothelial growth factor (VEGF) is an endothelial cell specific mitogen that induces angiogenesis in several pathological conditions. To block angiogenesis, soluble VEGF receptor can be used. In this study, we describe a method for high yield expression of soluble VEGF receptor 2 (sFlk-1) in a baculovirus expression system (30 mg purified sFlk-1 per L of insect cell supernatant). We also determined the binding constants for both human and mouse VEGF to the recombinant receptor by surface plasmon resonance. In this cell-free assay, under the given experimental conditions, the on-rate k(a) was 0.5-2.2 x 106 M-1 s-1 and the off-rate k(d) was 2-4 x 10-4 s-1 (K(D) = 2-6 x 10-10 M). To our knowledge this is the first study to report on- and off-rates for the VEGF:sFlk-1 interaction. Heparin was not required for the binding of VEGF to sFlk-1 in this assay. The obtained values will serve as baseline parameters for the design of improved versions of recombinant soluble VEGF receptor.",
author = "Xianming Huang and Claudia Gottstein and Brekken, {Rolf A.} and Thorpe, {Philip E.}",
year = "1998",
month = "11",
day = "27",
doi = "10.1006/bbrc.1998.9717",
language = "English (US)",
volume = "252",
pages = "643--648",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance

AU - Huang, Xianming

AU - Gottstein, Claudia

AU - Brekken, Rolf A.

AU - Thorpe, Philip E.

PY - 1998/11/27

Y1 - 1998/11/27

N2 - Vascular endothelial growth factor (VEGF) is an endothelial cell specific mitogen that induces angiogenesis in several pathological conditions. To block angiogenesis, soluble VEGF receptor can be used. In this study, we describe a method for high yield expression of soluble VEGF receptor 2 (sFlk-1) in a baculovirus expression system (30 mg purified sFlk-1 per L of insect cell supernatant). We also determined the binding constants for both human and mouse VEGF to the recombinant receptor by surface plasmon resonance. In this cell-free assay, under the given experimental conditions, the on-rate k(a) was 0.5-2.2 x 106 M-1 s-1 and the off-rate k(d) was 2-4 x 10-4 s-1 (K(D) = 2-6 x 10-10 M). To our knowledge this is the first study to report on- and off-rates for the VEGF:sFlk-1 interaction. Heparin was not required for the binding of VEGF to sFlk-1 in this assay. The obtained values will serve as baseline parameters for the design of improved versions of recombinant soluble VEGF receptor.

AB - Vascular endothelial growth factor (VEGF) is an endothelial cell specific mitogen that induces angiogenesis in several pathological conditions. To block angiogenesis, soluble VEGF receptor can be used. In this study, we describe a method for high yield expression of soluble VEGF receptor 2 (sFlk-1) in a baculovirus expression system (30 mg purified sFlk-1 per L of insect cell supernatant). We also determined the binding constants for both human and mouse VEGF to the recombinant receptor by surface plasmon resonance. In this cell-free assay, under the given experimental conditions, the on-rate k(a) was 0.5-2.2 x 106 M-1 s-1 and the off-rate k(d) was 2-4 x 10-4 s-1 (K(D) = 2-6 x 10-10 M). To our knowledge this is the first study to report on- and off-rates for the VEGF:sFlk-1 interaction. Heparin was not required for the binding of VEGF to sFlk-1 in this assay. The obtained values will serve as baseline parameters for the design of improved versions of recombinant soluble VEGF receptor.

UR - http://www.scopus.com/inward/record.url?scp=0032573553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032573553&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1998.9717

DO - 10.1006/bbrc.1998.9717

M3 - Article

C2 - 9837760

AN - SCOPUS:0032573553

VL - 252

SP - 643

EP - 648

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -